Towards precision medicine in diabetes: pharmacogenomic approaches for MODY and type 2 diabetes with insights from GLIS3 gene variants
This review evaluates pharmacogenomic evidence across monogenic and polygenic diabetes subtypes, presents Indian clinical case studies demonstrating the consequences of genomic misclassification, and positions GLIS3 as an underexplored regulatory gene with cross-disease relevance spanning neonatal diabetes, Type 1, and...